Clinical Trial Update: Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS) [NA]

View source ↗

Summary

A recruiting clinical trial evaluating the metabolic and clinical effects of magnesium and levocarnitine in women with polycystic ovary syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• LEVOCARNITINE (levocarnitine)
• Magnesium (magnesium)

Snippet

Sponsor: Behnood Abbasi | Conditions: Polycystic Ovary Syndrome (PCOS) | NA | Status: RECRUITING